RE:RE:RE:RE:RE:RE:USA Inflation Reduction Act (IRA) 2022 Re: Biotech and ChinaTo complete an acquisition in China, multinational companies have to go through a sometimes lengthy regulatory process involving antitrust and scrutiny over equity and the transfer of intellectual property, lawyers and analysts say, thus forcing non-Sino multinational companies to unwittingly enter into joint-ventures with Chinese companies, leading to those Chinese JV companies to subsequently transfer the intellectual property of the foreign companies to the Chinese government and the People's Liberation Army of China, and the knowledge gained to the benefit of China's developing biopharmaceutical industry. Effectively engaged in a form of corporate espionage.